JOHNSON & JOHNSON
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 36 trades on this page.
Director
Deferred Share Units
Derivative security · not the ordinary share price.
Director
Deferred Share Units
Derivative security · not the ordinary share price.
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
Director
Deferred Share Units
Derivative security · not the ordinary share price.
EVP, WW Chair, MedTech
Common Stock
EVP, WW Chair, MedTech
Common Stock
EVP, WW Chair, MedTech
Employee Stock Options (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
EVP, WW Chair, MedTech
Employee Stock Options (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
EVP, WWC. Innovative Medicine
Common Stock
EVP, WWC. Innovative Medicine
Employee Stock Options (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
CEO and Chairman of the Board
Common Stock
CEO and Chairman of the Board
Employee Stock Options (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
EVP, Chief Legal Officer
Common Stock
EVP, Chief Legal Officer
Employee Stock Options (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
EVP, Global Corp Affairs
Common Stock
EVP, Global Corp Affairs
Common Stock
EVP, Global Corp Affairs
Employee Stock Options (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
EVP, Global Corp Affairs
Employee Stock Options (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
EVP, Chief TO and Risk Officer
Common Stock
EVP, Chief TO and Risk Officer
Employee Stock Options (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Deferred Share Units
Derivative security · not the ordinary share price.
Director
Deferred Share Units
Derivative security · not the ordinary share price.
Director
Deferred Share Units
Derivative security · not the ordinary share price.
EVP, Innovative Medicine, R&D
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
EVP, Innovative Medicine, R&D
Common Stock
EVP, Innovative Medicine, R&D
Restricted Share Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Deferred Share Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Deferred Share Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Deferred Share Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Deferred Share Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Deferred Share Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Deferred Share Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Deferred Share Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Deferred Share Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Deferred Share Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Deferred Share Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Deferred Share Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Deferred Share UnitsGrant or award | Derivative units113$276.31 / derivative unit | $31.25K | Sep 8Filed Sep 10 · 2d later | SEC filing |
| Director | Deferred Share UnitsGrant or award | Derivative units136$276.31 / derivative unit | $37.5K | Sep 8Filed Sep 10 · 2d later | SEC filing |
| Director | Deferred Share UnitsGrant or award | Derivative units181$276.31 / derivative unit | $50K | Sep 8Filed Sep 10 · 2d later | SEC filing |
| EVP, WW Chair, MedTech | Common StockOption exercise or conversion | 11,070$131.94 / share | $1.46M | Sep 2Filed Sep 4 · 2d later | SEC filing |
| EVP, WW Chair, MedTech | Common StockOption exercise or conversion | 22,527$151.41 / share | $3.41M | Sep 2Filed Sep 4 · 2d later | SEC filing |
| EVP, WW Chair, MedTech | Employee Stock Options (Right to Buy)Option exercise or conversion | Derivative units11,070$131.94 exercise / conversion price | Not a separate purchase | Sep 2Filed Sep 4 · 2d later | SEC filing |
| EVP, WW Chair, MedTech | Employee Stock Options (Right to Buy)Option exercise or conversion | Derivative units22,527$151.41 exercise / conversion price | Not a separate purchase | Sep 2Filed Sep 4 · 2d later | SEC filing |
| EVP, WWC. Innovative Medicine | Common StockOption exercise or conversion | 15,000$115.67 / share | $1.74M | Aug 17Filed Aug 18 · 1d later | SEC filing |
| EVP, WWC. Innovative Medicine | Employee Stock Options (Right to Buy)Option exercise or conversion | Derivative units15,000$115.67 exercise / conversion price | Not a separate purchase | Aug 17Filed Aug 18 · 1d later | SEC filing |
| CEO and Chairman of the Board | Common StockOption exercise or conversion | 123,291$115.67 / share | $14.26M | Aug 13Filed Aug 14 · 1d later | SEC filing |
| CEO and Chairman of the Board | Employee Stock Options (Right to Buy)Option exercise or conversion | Derivative units123,291$115.67 exercise / conversion price | Not a separate purchase | Aug 13Filed Aug 14 · 1d later | SEC filing |
| EVP, Chief Legal Officer | Common StockOption exercise or conversion | 9,344$131.94 / share | $1.23M | Aug 6Filed Aug 7 · 1d later | SEC filing |
| EVP, Chief Legal Officer | Employee Stock Options (Right to Buy)Option exercise or conversion | Derivative units9,344$131.94 exercise / conversion price | Not a separate purchase | Aug 6Filed Aug 7 · 1d later | SEC filing |
| EVP, Global Corp Affairs | Common StockOption exercise or conversion | 11,129$129.51 / share | $1.44M | Jul 20Filed Jul 21 · 1d later | SEC filing |
| EVP, Global Corp Affairs | Common StockOption exercise or conversion | 11,925$131.94 / share | $1.57M | Jul 20Filed Jul 21 · 1d later | SEC filing |
| EVP, Global Corp Affairs | Employee Stock Options (Right to Buy)Option exercise or conversion | Derivative units11,129$129.51 exercise / conversion price | Not a separate purchase | Jul 20Filed Jul 21 · 1d later | SEC filing |
| EVP, Global Corp Affairs | Employee Stock Options (Right to Buy)Option exercise or conversion | Derivative units11,925$131.94 exercise / conversion price | Not a separate purchase | Jul 20Filed Jul 21 · 1d later | SEC filing |
| EVP, Chief TO and Risk Officer | Common StockOption exercise or conversion | 10,000$115.67 / share | $1.16M | Jun 11Filed Jun 12 · 1d later | SEC filing |
| EVP, Chief TO and Risk Officer | Employee Stock Options (Right to Buy)Option exercise or conversion | Derivative units10,000$115.67 exercise / conversion price | Not a separate purchase | Jun 11Filed Jun 12 · 1d later | SEC filing |
| Director | Deferred Share UnitsGrant or award | Derivative units161$232.79 / derivative unit | $37.5K | Jun 9Filed Jun 11 · 2d later | SEC filing |
| Director | Deferred Share UnitsGrant or award | Derivative units134$232.79 / derivative unit | $31.25K | Jun 9Filed Jun 11 · 2d later | SEC filing |
| Director | Deferred Share UnitsGrant or award | Derivative units215$232.79 / derivative unit | $50K | Jun 9Filed Jun 11 · 2d later | SEC filing |
| EVP, Innovative Medicine, R&D | Common StockOption exercise or conversion | 25,255$0 reported · see filing | Not established | May 1Filed May 4 · 3d later | SEC filing |
| EVP, Innovative Medicine, R&D | Common StockExercise-price or tax withholding | 11,002$229.85 / share | $2.53M | May 1Filed May 4 · 3d later | SEC filing |
| EVP, Innovative Medicine, R&D | Restricted Share UnitsOption exercise or conversion | Derivative units25,255Exercise / conversion price not reported | Not a separate purchase | May 1Filed May 4 · 3d later | SEC filing |
| Director | Deferred Share UnitsGrant or award | Derivative units975Award · no purchase price | Non-cash award | Apr 23Filed Apr 27 · 4d later | SEC filing |
| Director | Deferred Share UnitsGrant or award | Derivative units975Award · no purchase price | Non-cash award | Apr 23Filed Apr 27 · 4d later | SEC filing |
| Director | Deferred Share UnitsGrant or award | Derivative units975Award · no purchase price | Non-cash award | Apr 23Filed Apr 27 · 4d later | SEC filing |
| Director | Deferred Share UnitsGrant or award | Derivative units1,712Award · no purchase price | Non-cash award | Apr 23Filed Apr 27 · 4d later | SEC filing |
| Director | Deferred Share UnitsGrant or award | Derivative units1,540Award · no purchase price | Non-cash award | Apr 23Filed Apr 27 · 4d later | SEC filing |
| Director | Deferred Share UnitsGrant or award | Derivative units975Award · no purchase price | Non-cash award | Apr 23Filed Apr 27 · 4d later | SEC filing |
| Director | Deferred Share UnitsGrant or award | Derivative units975Award · no purchase price | Non-cash award | Apr 23Filed Apr 27 · 4d later | SEC filing |
| Director | Deferred Share UnitsGrant or award | Derivative units975Award · no purchase price | Non-cash award | Apr 23Filed Apr 27 · 4d later | SEC filing |
| Director | Deferred Share UnitsGrant or award | Derivative units975Award · no purchase price | Non-cash award | Apr 23Filed Apr 27 · 4d later | SEC filing |
| Director | Deferred Share UnitsGrant or award | Derivative units975Award · no purchase price | Non-cash award | Apr 23Filed Apr 27 · 4d later | SEC filing |
| Director | Deferred Share UnitsGrant or award | Derivative units975Award · no purchase price | Non-cash award | Apr 23Filed Apr 27 · 4d later | SEC filing |
Johnson & Johnson Common Stock (JNJ) · Stock
The filing reports a purchase for the member.
Lloyd DoggettReporting House memberJohnson & Johnson Common Stock (JNJ) · Stock
The filing reports a partial sale for the member.
Thomas H. Kean JrReporting House memberJohnson & Johnson Common Stock · Stock
The filing reports a partial sale for a joint account.
John BoozmanReporting Senate memberJohnson & Johnson Common Stock (JNJ) · Stock
The filing reports a sale for the member.
Richard Dean Dr McCormickReporting House memberJohnson & Johnson Common Stock · Stock
The filing reports a full sale for a joint account.
Thomas H TubervilleReporting Senate memberJohnson & Johnson Common Stock · Stock
The filing reports a full sale for a joint account.
Thomas H TubervilleReporting Senate memberJohnson & Johnson Common Stock · Stock
The filing reports a purchase for the member.
Johnson & Johnson Common Stock · Stock
The filing reports a purchase for the member.
Johnson & Johnson Common Stock (JNJ) · Stock
The filing reports a partial sale for the member.
Thomas H. Kean JrReporting House memberJohnson & Johnson Common Stock (JNJ) · Stock
The filing reports a partial sale for the member.
Thomas H. Kean JrReporting House memberJohnson & Johnson Common Stock (JNJ) · Stock
The filing reports a purchase for the member.
Lloyd DoggettReporting House memberJohnson & Johnson Common Stock · Stock
The filing reports a partial sale for a joint account.
John BoozmanReporting Senate memberJohnson & Johnson Common Stock (JNJ) · Stock
The filing reports a partial sale for the member.
Thomas H. Kean JrReporting House memberJohnson & Johnson Common Stock (JNJ) · Stock
The filing reports a partial sale for the member.
Richard Dean Dr McCormickReporting House memberJohnson & Johnson Common Stock (JNJ) · Stock
The filing reports a partial sale for the member.
Richard Dean Dr McCormickReporting House memberJohnson & Johnson Common Stock (JNJ) · Stock
The filing reports a purchase for the member.
Lloyd DoggettReporting House memberJohnson & Johnson Common Stock (JNJ) · Stock
The filing reports a partial sale for the member.
Thomas H. Kean JrReporting House memberJohnson & Johnson Common Stock (JNJ) · Stock
The filing reports a sale for a joint account.
Julie JohnsonReporting House memberJohnson & Johnson Common Stock (JNJ) · Stock
The filing reports a purchase for the member.
Lloyd DoggettReporting House memberJohnson & Johnson Common Stock (JNJ) · Stock
The filing reports a partial sale for the member.
Thomas H. Kean JrReporting House memberJohnson & Johnson Common Stock (JNJ) · Stock
The filing reports a partial sale for a joint account.
Julie JohnsonReporting House memberJohnson & Johnson Common Stock (JNJ) · Stock
The filing reports a purchase for the member.
Richard Dean Dr McCormickReporting House memberJohnson & Johnson Common Stock (JNJ) · Stock
The filing reports a partial sale for a dependent.
Jared MoskowitzReporting House memberJohnson & Johnson Common Stock (JNJ) · Stock
The filing reports a partial sale for a dependent.
Jared MoskowitzReporting House memberJohnson & Johnson Common Stock (JNJ) · Stock
The filing reports a sale for a spouse.
Lisa McClainReporting House memberShowing the latest 25 of 29 disclosed trades. Show all 29 trades
